AMRI saw revenue growth in Q1 2011 driven by its contract manufacturing business. AMRI's development and small scale manufacturing revenue grew 24% to $10.5m and large scale manufacturing revenue grew 22% to $21.8m. The company has recently resumed GMP production at its Burlington, MA, facility and is working with the FDA to close out the Warning Letter as soon as possible.
AMRI
Wednesday 4 May 2011
Q1 contract revenues grow for AMRI
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment